Presentation of immunogenicity related information in regulatory dossiers

In this supplement Paul Chamberlain explains how an integrated summary report can be created to consolidate the information required for assessment of immunogenicity-related risks of different types of biopharmaceuticals.

Download article

Fill out the form on the right to download this article. 

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World